As for further strategies for pSS therapy, a report described that belimumab combined with RTX may be useful for SS-related B-cell lymphoproliferation and overexpressed B-cell activating factor (BAFF) in MALT. This evidence concerns the gene TNFSF13B and synovial sarcoma.